share_log

Kiora Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Stengone Carmine N.

SEC announcement ·  Aug 10, 2023 17:23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more